Australia’s trusted immunisation experts
30 April 2024 | NewsWorld Immunization Week 2024 – 50 years of global progressRead the full article
Coversheet on evidence assessment: CVD 103–HgR (Vaxchora) in children and adults
Use of CVD 103–HgR (Vaxchora) cholera vaccine compared to placebo in children and adults aged ≥2 years who have a high risk of exposure to cholera
Compared to placebo in children and adults aged ≥2 years who have a high risk of exposure to cholera
Note: These GRADE documents should be read as a supplement to Australian Immunisation Handbook recommendations.
View the cholera disease chapter in the Australian Immunisation Handbook